جستجوی استاد راهنمای دانشگاهی

• Zebrafish Research
• Vascular Biology
• Lymphatic Development
• +۳ مورد دیگر

Dr. Kazuhide Shaun Okuda is a Senior Lecturer and Group Leader at the La Trobe Institute for Molecular Science, Department of Biochemistry and Chemistry at La Trobe University, Australia. He also holds honorary positions at Peter MacCallum Cancer Centre and the University of Melbourne. With extensive experience in zebrafish research and vascular biology, Dr. Okuda has established himself as an expert in lymphatic development, disease modeling, and drug discovery. Dr. Okuda earned his PhD in Molecular Medicine from the University of Auckland, New Zealand (2010-2014), where he generated groundbreaking zebrafish transgenic lines for lymphatic vessel imaging. His subsequent postdoctoral work at Cancer Research Malaysia and the University of Queensland/Peter MacCallum Cancer Centre focused on anti-cancer therapeutics screening and dynamic signaling events during development and regeneration. His research focuses on understanding lymphoedema mechanisms, identifying therapies that modulate vascular growth, and elucidating dynamic mechanisms of vascular development and disease progression. Dr. Okuda's work has significant potential impact in developing new treatments for lymphoedema and diseases with excessive vascular growth such as cancer and lymphatic malformations. Analysis of Dr. Okuda's publication record shows a consistent focus on vascular and lymphatic development using zebrafish models. His most recent work (2023-2025) demonstrates an expansion into drug delivery systems, advanced imaging techniques, and single-cell analysis approaches while maintaining his core interest in lymphangiogenesis mechanisms and therapeutic interventions. Dr. Okuda has received significant research funding, including a National Health and Medical Research Council Ideas Grant (2024-2027) for his project on 'Cellular signalling and growth control in vascular development and lymphatic malformations.' Primary supervisor of PhD students (X4), La Trobe University (2023-present) Co-supervisor of PhD students (X3), University of Melbourne (2020-present) Co-supervisor of a PhD student, La Trobe University (2023-present) Senior Lecturer and Group Leader, La Trobe Institute for Molecular Science (2023-present) Honorary Scientist, Peter MacCallum Cancer Centre (2023-present) Honorary Fellow, University of Melbourne (2020-present) Dr. Okuda leads a research group at the La Trobe Institute for Molecular Science focused on identifying therapeutic leads/targets that modulate the vasculature and studying dynamic signaling mechanisms in endothelial cells using zebrafish models. His team has made significant contributions to understanding lymphatic development, including the identification of Ddx21 and ribosome biogenesis as novel regulators of embryonic lymphangiogenesis.

Orlagh Feeneyمشاهده پروفایل

پژوهشگر ارشد

• Advanced Drug Delivery
• Pharmacokinetics
• Lymphatic Transport
• +۳ مورد دیگر

Orlagh Feeney is a Research Fellow and Nanomedicine team lead in the Porter Group at Monash Institute of Pharmaceutical Sciences (MIPS), Monash University. She specializes in advanced drug delivery systems with a focus on cancer and autoimmune diseases, emphasizing translational research derived from her six-year pharmaceutical R&D experience in Ireland. Her research interests include controlling pharmacokinetics, lymphatic exposure, and targeted drug delivery strategies such as active targeting and stromal modification. She leads projects like the 'Role of Hyaluronan in Antigen and Immune Cell Trafficking' and developed disease models for solid cancers and collagen-induced arthritis. Key contributions include studies on polymer nanorod-drug conjugates, intestinal lymphatic drug delivery, and lymphatic targeting of immunotherapies. She co-edited a Molecular Pharmaceutics special issue on Australasian innovations and serves as a peer reviewer. Feeney's work aligns with UN SDGs addressing good health and well-being, leveraging lymphatic pathways to enhance therapeutic efficacy in oncology and autoimmune therapies.

• Public Health
• Implementation Science
• Clinical Trials
• +۷ مورد دیگر

Sonali Munot is a Research Fellow at the Westmead Applied Research Centre within the Faculty of Medicine and Health at the University of Sydney. She is affiliated with the Charles Perkins Centre , focusing on health equity and implementation science.

• Tissue Engineering
• Vascular Biology
• Stem Cell Research
• +۳ مورد دیگر

Geraldine Mitchell is a Clinical Associate Professor in the School of Nursing, Midwifery and Paramedicine, Faculty of Health Sciences. Her research focuses on advancing regenerative medicine through tissue engineering and vascular biology, particularly in liver bioengineering, endothelial cell function, and the development of functional vascular networks. She employs interdisciplinary approaches involving stem cells, biomaterials, and in vivo models to address challenges in organoid differentiation, fat graft survival, and adipose-derived progenitor cell potential. Her work explores the role of endothelial cells in modulating organoid development and leverages innovative methods like vascularized bioreactors and porous scaffolds to enhance tissue viability. Key contributions include studies on nitric oxide signaling in stem cell differentiation, epigenetic profiling of adipose-derived progenitors, and the application of microRNAs to understand metabolic disorders. Research interests span liver niche recapitulation, angiogenesis regulation via PI(4,5)P2 pathways, and the integration of biocompatible materials for 3D scaffold vascularization. Collaborations with multidisciplinary teams emphasize translational applications in regenerative medicine and biomedical engineering.

Matt Rutarمشاهده پروفایل

دانشیار

• Retinal Degenerative Diseases
• Immunology
• Ophthalmology
• +۳ مورد دیگر

Matt Rutar is an Associate Professor in the Department of Biomedical Science, Molecular & Biochemical Therapeutics at the University of Canberra, within the Faculty of Science and Technology. His research focuses on understanding molecular and cellular drivers of vision-threatening retinal diseases, particularly age-related macular degeneration (AMD). He holds an Honorary Senior Fellow position at the University of Melbourne's Anatomy and Neuroscience department. Education: PhD in Biomedical Science from Australian National University (2008-2011). Postdoctoral research at John Curtin School of Medical Research (JCSMR) and the University of Melbourne, where he established an independent laboratory funded by NHMRC grants. Research interests include immunological mechanisms in retinopathies, environmental/lifestyle influences on eye disease, and developing therapeutic targets for AMD. He leads projects funded by organizations like the Ophthalmic Research Institute of Australia and NHMRC, including studies on neutrophils in choroidal neovascularization and Wnt signaling in multiple sclerosis. Advising: Open to supervising PhD/Masters/Honours students in his research themes. His work bridges basic science and clinical applications, aiming to translate immune regulation discoveries into novel therapies for retinal disorders. Current laboratory facilities at University of Canberra support advanced molecular and cellular investigations into retinal pathologies.

• Biomedical Engineering
• Mathematical Biology
• Biophysics
• +۳ مورد دیگر

Associate Professor Charles Macaskill is affiliated with the Faculty of Science at the University of Sydney. His research focuses on mathematical and computational modeling in biomedical systems, particularly lymphatic muscle physiology, fluid dynamics in embryonic tissues, and cardiovascular-related phenomena. He collaborates internationally, as evidenced by grants from the NIH and ARC. Key research interests include lymphatic pacemaking mechanisms, atherosclerotic plaque dynamics, and the biophysical underpinnings of cellular signaling pathways. His work bridges theoretical models with experimental data, addressing clinical conditions like lymphedema and cardiovascular disorders. Recent publications emphasize lymphatic valve formation, ion channel effects on muscle cell behavior, and fluid dynamics in developmental systems. He has secured significant grants for projects such as 'Lymphatic pacemaking and pumping in lymphedema' and 'Dynamics of atherosclerotic plaque formation'.

• Drug Delivery
• Lymphatic Biology
• Pharmaceutical Sciences
• +۳ مورد دیگر

Gracia Gracia is a Research Fellow in the Department of Drug Delivery, Disposition & Dynamics at Monash University. Her research focuses on advanced drug delivery systems, lymphatic biology, and lipid-based therapeutic strategies. She leads the 2015-2018 Victorian International Research Scholarship project as Primary Chief Investigator, investigating drug disposition mechanisms. Her work contributes to the UN Sustainable Development Goals through innovations in pharmaceutical science and biomedical engineering. Education: PhD in Pharmaceutical Sciences (implied) Key research areas include polymer conjugation for extended drug half-lives, lipid trafficking pathways, and lymphatic transport dynamics. She has authored over 15 peer-reviewed articles, with recent studies published in Acta Biomaterialia , Science Advances , and Pharmacological Reviews . Her 2024 review article provides comprehensive insights into current drug delivery challenges and future therapeutic directions. Gracia collaborates with institutions globally on metabolic and biomedical projects. Notable collaborations include work with Prof. Trevaskis on chylomicron assembly and Prof. Nicolazzo on brain lymphatic transport mechanisms. She has secured research funding through competitive grants and holds an Open Access publication record. Her research teams explore translational applications in controlled release systems and lipid-based therapies, with potential impacts on chronic disease management and personalized medicine.

Klaus-Martin Schulteمشاهده پروفایل

استاد

• Indigenous Pharmacogenomics
• Space Medicine
• Cancer Biology
• +۳ مورد دیگر

Prof. Klaus-Martin Schulte is the Professor & Chair of Transdisciplinary Health Research at the Australian National University (ANU) and holds an Honorary Reader position at King's College London. His clinical roles include Consultant Endocrine and General Surgeon at King’s College Hospital (part-time since 2014) and Lead Clinician in Endocrine Surgery. He has extensive experience in surgical oncology, endocrine disorders, and translational research. Education: MD from University of Duisburg-Essen (1990) Postgraduate training at Harvard Medical School, Baylor College of Medicine, and University of Paris PhD in molecular endocrinology (1990) FRACS (Fellow of the Royal Australasian College of Surgeons) and FRCS (Fellow of the Royal College of Surgeons of England) Research Interests: Focus on Indigenous Pharmacogenomics , Space Medicine , and Cancer Biology . His work includes developing surgical oncology protocols for endocrine cancers (e.g., parathyroid carcinoma, pheochromocytoma) and investigating space-related health challenges like microgravity effects on cardiovascular systems. Key Projects: iLAuNCH: Wearable health solutions for space medicine Pharmacogenomics pipeline for Indigenous health equity Software-defined radio for satellite communications Awards: von Langenbeck Award for surgical innovation (2002) Oberdisse Award for thyroid research (1998) Multiple Clinical Excellence Awards (2004–present) Grants & Funding: Principal investigator in 4 DFG-funded projects and multiple NHMRC-like grants. Current leadership roles in ANU’s Transdisciplinary Health Research division. Future Work: Expanding space medicine collaborations and advancing precision medicine for endocrine tumors.

Joseph Nicolazzoمشاهده پروفایل

استاد

• Blood-Brain Barrier
• Alzheimer's Disease
• Drug Transport
• +۳ مورد دیگر

Joseph Nicolazzo is a Professor and Director of the Centre for Drug Candidate Optimisation (CDCO) at the Monash Institute of Pharmaceutical Sciences, Monash University. He concurrently serves as Associate Dean (International) in the Faculty of Pharmacy and Pharmaceutical Sciences. With a PhD in buccal mucosal drug delivery (2004, Monash University), he has led research on BBB transport mechanisms, Alzheimer’s disease, and neurodegenerative disorders since 2007. His work spans in vitro/in vivo models to understand drug transport dynamics and BBB dysfunction in diseases like ALS and Alzheimer’s. Nicolazzo has authored 115+ peer-reviewed papers and holds editorial roles in journals like the Journal of Pharmaceutical Sciences and Fluids and Barriers of the CNS . Education: PhD in Pharmacy (2004, Monash University). Research Focus: Blood-brain barrier transporters, Alzheimer’s pathobiology, CNS drug delivery. Awards: FIP Award of Recognition (2014), Early Career Researcher Award (2013). His teaching includes coordinating PHR2021 and lecturing in drug delivery and pharmacokinetics. Nicolazzo leads ~32 active research projects, including drug delivery strategies for brain cancer and BBB-targeted therapies. He collaborates internationally on BBB biology and chairs FIP’s Pharmaceutical Sciences Board. Labs/Teams: Directs the CDCO, a hub for ADME expertise in drug development. Active in interdisciplinary teams exploring BBB dysfunction in neurodegenerative diseases.

• Lymphatic Biology
• Drug Delivery
• Metabolic Diseases
• +۴ مورد دیگر

Dr. Enyuan Cao is a Research Fellow in the Department of Drug Delivery Disposition & Dynamics at Monash University. His research focuses on lymphatic biology, drug delivery systems, and metabolic diseases, with particular emphasis on how lymphatic dysfunction contributes to obesity, inflammation, and therapeutic efficacy. Cao leads major projects funded by the Australian Research Council (ARC) and National Health and Medical Research Council (NHMRC), including initiatives on lymph-targeted cancer therapies and nanoemulsion drug design. His recent work explores lymphatic transport mechanisms for antibodies (e.g., anti-CTLA4), brain-draining lymphatics, and obesity-induced lymphatic leakage. Collaborations span institutions globally, addressing topics like ceramide metabolism in chylomicrons and hyaluronan's role in drug delivery. Cao also organizes professional development workshops for early-career researchers. Key projects include: 2023-2027: NHMRC-funded investigation into lymph-resident targets for inflammatory diseases 2025-2028: ARC-funded development of biomimetic lipid drug carriers 2023-2027: Pancreatic cancer research targeting lymph-pancreas interactions Publications highlight advancements in lymphatic drug delivery, metabolic syndrome mechanisms, and lymphatic dysfunction's role in insulin resistance. His lab innovates methods like cervical lymph collection in rodents and software (Vmeasur) for lymphatic flow analysis.

Angus McLureمشاهده پروفایل

پژوهشگر ارشد

• Mathematical modelling of infectious diseases
• Molecular xenomonitoring
• Surveillance and interventions in the endgame of elimination campaigns
• +۳ مورد دیگر

Dr Angus McLure is a Research Fellow at the National Centre for Epidemiology and Population Health at The Australian National University. His work focuses on mathematical modeling of infectious diseases, with particular expertise in lymphatic filariasis elimination, molecular xenomonitoring, and foodborne disease source attribution. He has developed analytical tools including the R package PoolTestR for molecular xenomonitoring data analysis and has collaborated extensively with researchers like Katie Glass and Martyn Kirk across multiple disease systems. Dr McLure completed his PhD in Epidemiology at ANU from 2015 to 2019, following a Bachelor of Philosophy (Honours) in Science from 2011 to 2014. His academic journey at ANU has positioned him as a key contributor to infectious disease modeling research within the Centre of Epidemiology for Policy and Practice and the Infectious Diseases and Modelling Group. His research spans multiple infectious disease domains with a strong emphasis on mathematical modeling approaches. Dr McLure has made significant contributions to understanding lymphatic filariasis transmission dynamics and elimination pathways, as well as foodborne disease epidemiology. His work addresses critical public health questions related to disease elimination strategies, surveillance methods, and source attribution across pathogens including Campylobacter, Salmonella, C. difficile, and Dengue. His publication record shows a strong focus on lymphatic filariasis elimination strategies and foodborne disease modeling, with 24 research outputs between 2017-2025. The articles demonstrate expertise in mathematical modeling, molecular epidemiology, and public health intervention evaluation, often bridging theoretical modeling with practical public health applications in disease elimination and food safety contexts. Dr McLure is actively involved in multiple research projects including 'New tools to accelerate elimination of the preventable parasite disease lymphatic filariasis' (2025-2028), 'Estimate the cost of foodborne illness by food commodities and pathogens' (2023), and previous projects on foodborne illness source attribution. His h-index of 9 reflects his growing impact in the field of infectious disease epidemiology and mathematical modeling.

• Musculoskeletal Physiotherapy
• Ankle Instability
• Lower Limb Injuries
• +۵ مورد دیگر

Dr. Marcos De Noronha serves as a Senior Lecturer in Physiotherapy at La Trobe University's Bendigo Campus within the La Trobe Rural Health School, where he has been employed since July 2012. His academic appointments and research activities are centered in the Physiotherapy department, focusing on evidence-based clinical practice and research in musculoskeletal conditions. His educational background includes: Bachelor of Physiotherapy from Federal University of São Carlos, São Carlos, Brazil (1994-1997) Certificate of Hydrotherapy from Universidade Tuiuti do Paraná, Curitiba, Brazil (1998-1999) Master of Human Movement Science from UDESC, Florianopolis, Brazil (2000-2001) PhD from University of Sydney, Sydney, Australia (2003-2007) Dr. De Noronha's research program demonstrates significant expertise in musculoskeletal physiotherapy, with particular focus on ankle instability, lower limb injuries, and knee osteoarthritis. His work often employs systematic review methodology, reflecting his commitment to evidence-based practice. He is also the co-author of a Cochrane Systematic Review on the effects of stretching on muscle soreness, highlighting his contribution to high-impact evidence synthesis in the field. His research extends to biomechanics, rehabilitation protocols, and clinical effectiveness of various physiotherapy interventions. Analysis of his recent publication record (2023-2025) reveals a strong emphasis on systematic reviews and clinical trials across multiple musculoskeletal conditions, particularly focusing on neck pain, knee osteoarthritis, and injury prevention. His work increasingly incorporates innovative methodologies including video-based assessment, telerehabilitation approaches, and quantitative sensory testing. The research demonstrates a clear trajectory toward understanding barriers to rehabilitation adherence, developing novel assessment tools, and examining the biomechanical aspects of common musculoskeletal conditions. Dr. De Noronha has been actively involved in research supervision, serving as joint supervisor for at least one research degree project titled 'The effects of sports specific fatigue in ankle joint, after a single leg drop jump in healthy participants' (2016-2018). He has secured external research funding from the Sao Paulo Research Foundation for a project examining 'The effects of different exercise protocols and different delivery methods on the progression of knee osteoarthritis' (2017-2018). His collaborative network is evident through his numerous co-authored publications across various institutions and countries, reflecting an active research program with multiple ongoing projects.

• Gynaecological Oncology
• Cervical Cancer
• Ovarian Cancer
• +۵ مورد دیگر

Professor Jonathan Carter is a Professor of Gynaecological Oncology at the University of Sydney's Central Clinical School, affiliated with the Department of Obstetrics, Gynaecology and Neonatology. He holds clinical roles as Clinical Director of Women's Health Neonatology and Paediatrics at the Sydney Local Health District and Director of RPA Women and Babies. His research focuses on cervical and gynaecological cancers, surgical management innovations, and enhanced recovery protocols post-surgery. Key interests include cervical cancer screening, minimally invasive surgical techniques, and outcomes of ovarian/endometrial cancer treatments. Research interests span surgical oncology advancements, such as robotic vs. laparoscopic approaches, and translational studies on cancer biomarkers. He has contributed to guidelines for post-treatment surveillance protocols and fast-track surgery programs. Over 100 peer-reviewed publications reflect his work in gynaecological oncology, including surgical outcomes, molecular studies, and clinical trials. Notable collaborations include multinational studies on BRCA mutations and ovarian cancer risk factors. His articles highlight trends in minimally invasive surgery, cancer metastasis mechanisms, and genetic risk assessment. Grants include projects on decision aids for ovarian cancer patients and improving communication in clinical care. No scientific awards are explicitly listed, but his prolific research output underscores his academic contributions. Advising and grants include a 2006 project on decision-making tools for ovarian cancer patients. Clinical and academic leadership roles emphasize his commitment to centralising gynaecological oncology care in Australia. He collaborates with Sydney's Royal Prince Alfred Hospital and other institutions in translational research and clinical service development.

Colleen Lauمشاهده پروفایل

استاد

• Emerging infectious diseases
• Neglected tropical diseases
• Clinical travel medicine
• +۱۲ مورد دیگر

Professor Colleen Lau is an NHMRC Fellow and Professorial Research Fellow at the UQ Centre for Clinical Research within the Faculty of Health, Medicine and Behavioural Sciences at The University of Queensland. She holds multiple affiliations including as an Affiliate of the Queensland Digital Health Centre and Honorary Academic positions at Australian National University and James Cook University. Her extensive professional memberships include the Royal Australian College of General Practitioners, Australasian College of Tropical Medicine, and International Society of Travel Medicine. Professor Lau's research spans emerging infectious diseases, neglected tropical diseases, and clinical travel medicine. Her expertise encompasses infectious disease epidemiology, spatial epidemiology and disease mapping, infectious disease surveillance and elimination, vaccinations, travel health, environmental health, and digital decision support tools. She leads UQ's HERA program on Operational Research and Decision Support for Infectious Diseases (ODeSI), focusing on answering practical questions in clinical management of infectious diseases and operational questions for improving public health strategies. Her recent publications demonstrate strong focus on lymphatic filariasis elimination efforts in the Pacific Islands, leptospirosis epidemiology, travel medicine applications, and digital decision support tools. Her work often employs spatial epidemiological methods and integrates multiple data sources to address complex public health challenges, particularly in resource-limited settings and the Pacific region. NHMRC Fellow FRACGP (Fellow of the Royal Australian College of General Practitioners) FACTM (Fellow of the Australasian College of Tropical Medicine) FISTM (Fellow of the International Society of Travel Medicine) Professor Lau actively supervises numerous PhD students working on diverse projects related to infectious disease epidemiology, surveillance systems, and public health interventions across multiple countries. She has established strong collaborations with international partners including World Health Organization, US Centers for Disease Control and Prevention, and multiple Pacific Island Ministries of Health. Her research group develops innovative tools including the Japanese encephalitis vaccine risk-benefit tool (JET), PoolTestR package, and CoRiCAL COVID-19 vaccine risk-benefit calculator. Her laboratory, the ODeSI program, focuses on operational research to inform infectious disease prevention, control, and elimination through multidisciplinary partnerships with clinical and public health decision makers. The team specializes in field surveys, spatial epidemiology, clinical epidemiology, surveillance systems, systematic reviews, and novel epidemiological methods including machine learning and social network analysis.

Barry Censeمشاهده پروفایل

دانشیار

• Optical Coherence Tomography (OCT)
• Retinal Imaging
• Oculomics
• +۵ مورد دیگر

Barry Cense is an Associate Professor and Research Professor in the School of Engineering at The University of Western Australia (UWA), with an additional Research Professor position at Yonsei University (2020–2013). His expertise spans Bioengineering, Medical Devices, and Diagnostics, with a focus on Optical Coherence Tomography (OCT) and its applications in healthcare. He holds a PhD in Biophysical Engineering from TU Twente (2005) and a BSc in Applied Physics from Fontys University of Applied Sciences (1995). His research emphasizes Oculomics, leveraging OCT to study systemic diseases via retinal scans. Key areas include diagnosing cardiovascular diseases (e.g., hypertension, coronary artery disease) through retinal blood vessel analysis, non-invasive asthma imaging using bronchoscopic OCT, and terahertz imaging for corneal hydration studies. He has pioneered over 60 peer-reviewed papers and 13 patents, cited over 13,600 times. Teaching roles include coordinating UWA’s ENSC2001 (Motion) and ELEC5552 (Design), involving hands-on projects like autonomous vehicle development and industry-linked capstone prototypes. Notable grants include projects on retinal screening for cardiovascular diseases, asthma treatment optimization, and corneal hydration analysis. Awards include the 2020 National Research Foundation Korea BrainPool fellowship. Collaborations span institutions globally, with active projects on lung imaging, burn scar assessment, and alternatives to mulesing in livestock. His work aligns with UN Sustainable Development Goals, particularly in advancing healthcare and education through innovative biomedical technologies.